Martin M.
- Country
- France
- Department
- Medecine interne
Research Overview
- HydroxyChloroquine as steroid-sparing Agent in Extra-pulmonary SARcoidosis. A multicenter, prospective, placebo-controlled, randomized trial. CAESAR
- Phase II Study Evaluating the Efficacy and Safety of Secukinumab versus Combination Therapy in Patients with Active Severe Takayasu Arteritis
- A Phase 2 Study to Evaluate the Efficacy and Safety of Transitioning to KPL-387 Monotherapy in Participants with Well-Controlled Recurrent Pericarditis
Data & Insights
Has run more than one trial at 25 of 72 partner sites.
Specializations
Inflammatory Disorders
The investigator specializes in treating sarcoidosis, with particular emphasis on innovative therapeutic approaches for both pulmonary and extra-pulmonary manifestations. Their research explores TNF-alpha antagonist treatments and maintenance strategies for patients in remission.
- Extra-pulmonary sarcoidosis management
- Steroid-sparing treatments
- Remission maintenance protocols
Autoimmune Conditions
The investigator focuses on the treatment of Giant Cell Arteritis, investigating advanced therapeutic interventions including biological treatments. Their work includes evaluation of tocilizumab discontinuation strategies and long-term disease management approaches.
- Vasculitis treatment protocols
- Biological therapy optimization
- Relapse prevention strategies
Therapeutic Innovation
The investigator explores novel applications of established medications, including hydroxychloroquine as a steroid-sparing agent. Their work encompasses systematic evaluation of alternative treatment strategies for immune system disorders.
- Alternative treatment pathways
- Drug optimization studies
- Medication withdrawal protocols
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.